On and effective June 1, 2022, Debra Peattie, PhD, MBA gave notice to Inhibitor Therapeutics, Inc. (the Company) of her retirement from the Board of Directors of the Company (the Board). The purpose of Dr. Peattie's retirement is to focus on other professional opportunities and not based on any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.089 USD | +0.03% | -35.32% | -3.26% |
03-29 | Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board | CI |
1st Jan change | Capi. | |
---|---|---|
-3.26% | 15.31M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- INTI Stock
- News Inhibitor Therapeutics, Inc.
- Inhibitor Therapeutics, Inc. Announces Retirement of Debra Peattie from the Board of Directors